Developing biomarkers for cerebral amyloid angiopathy trials: do potential disease phenotypes hold promise? Reply

Author(s):
Greenberg, S.M.; Salman, R.A.S.; Biessels, G.J.; Buchem, M. van; Cordonnier, C.; Lee, J.M.; Montaner, J.; Schneider, J.A.; Smith, E.E.; Vernooij, M.; Werring, D.J.
Published
2014
Publication type
Article / Letter to editor
Date issued
2014-06-30
Language
English
Is part of
The Lancet Neurology (2014), Vol. 13, no. 6, p. 540-540
hdl
1887/103694